review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Robert L Findling | |
Sylvester Smarty | |||
P2860 | cites work | A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group | Q28139401 |
A children's global assessment scale (CGAS) | Q28271291 | ||
A Double-Blind, Placebo-Controlled, Prophylaxis Study of Lamotrigine in Rapid-Cycling Bipolar Disorder | Q29394100 | ||
A rating scale for mania: reliability, validity and sensitivity | Q29619299 | ||
A case series of eight aggressive young children treated with risperidone | Q30775353 | ||
Case study: carbamazepine treatment of juvenile-onset bipolar disorder | Q33543929 | ||
Risperidone treatment for juvenile bipolar disorder: a retrospective chart review | Q33703978 | ||
Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder | Q33814162 | ||
A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. | Q33844681 | ||
Pharmacologic agents for the treatment of acute bipolar mania. | Q34052819 | ||
A diagnostic interview: the schedule for affective disorders and schizophrenia | Q34269355 | ||
Mania-Like Symptoms Suggestive of Childhood-Onset Bipolar Disorder in Clinically Referred Children | Q34303286 | ||
Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group | Q34514128 | ||
Adjunctive topiramate treatment for pediatric bipolar disorder: a retrospective chart review | Q35081231 | ||
Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference | Q35153322 | ||
Mood stabilizers in hospitalized children with bipolar disorder: a retrospective review | Q35209742 | ||
Adjunctive gabapentin treatment of bipolar disorder. | Q53900501 | ||
An open label study of gabapentin in the treatment of acute mania. | Q53943806 | ||
Response to clozapine in acute mania is more rapid than that of chlorpromazine. | Q53972337 | ||
Quetiapine for refractory mania in a child. | Q54313395 | ||
Risk of Substance Use Disorders in Adolescents With Bipolar Disorder | Q57400365 | ||
Age at Onset, Childhood Psychopathology, and 2-Year Outcome in Psychotic Bipolar Disorder | Q60627447 | ||
Clozapine for Treatment-Refractory Schizophrenia, Schizoaffective Disorder, and Psychotic Bipolar Disorder | Q60633571 | ||
Clozapine for treatment-refractory mania | Q71085936 | ||
Preliminary studies of the reliability and validity of the children's depression rating scale | Q71328354 | ||
The VA-NIMH Study of Lithium in Affective Disorders | Q71571554 | ||
The efficacy and safety of divalproex sodium in the treatment of acute mania in adolescents and young adults: an open clinical trial | Q72316118 | ||
Clozapine treatment of bipolar disorder in a young adolescent | Q72895716 | ||
Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young | Q73125631 | ||
Carbamazepine treatment of bipolar disorder in an adolescent with cerebral palsy | Q73877763 | ||
Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder | Q74502628 | ||
Gabapentin in the treatment of adolescent mania: a case report | Q74695452 | ||
Adjunctive antipsychotic treatment is necessary for adolescents with psychotic mania | Q77624570 | ||
Olanzapine in the treatment of adolescent acute mania: a report of seven cases | Q77997203 | ||
Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype | Q80042732 | ||
An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression | Q82844580 | ||
A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania | Q82844588 | ||
Lithium treatment of acute mania in adolescents: a large open trial | Q44576750 | ||
Open-label olanzapine treatment in five preadolescent children | Q44672466 | ||
A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression. | Q44787822 | ||
Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode | Q44801076 | ||
A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. | Q44877765 | ||
Response to clozapine of rapid cycling versus non-cycling patients with a history of mania | Q44957587 | ||
Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study | Q44987700 | ||
Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania | Q45168239 | ||
Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol | Q45168624 | ||
Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. | Q45206307 | ||
Oxcarbazepine treatment of juvenile-onset bipolar disorder | Q45223984 | ||
Ziprasidone monotherapy in pediatric bipolar disorder | Q45224004 | ||
Aripiprazole in the treatment of bipolar disorder in children and adolescents | Q45232217 | ||
A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder | Q45237779 | ||
Six-year-old Thomas diagnosed with pediatric onset bipolar disorder: a case study | Q45257714 | ||
Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group | Q45338046 | ||
Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. | Q46377270 | ||
Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder | Q46448298 | ||
A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder | Q46503060 | ||
A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression | Q46580881 | ||
Lamotrigine add-on to valproate therapy for paediatric bipolar affective disorder | Q46582007 | ||
Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial | Q46596821 | ||
Risperidone in the treatment of acute mania: double-blind, placebo-controlled study | Q46681460 | ||
Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial | Q46681464 | ||
Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children | Q46765699 | ||
An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorder | Q46827368 | ||
Combination lithium and divalproex sodium in pediatric bipolar symptom re-stabilization | Q46905721 | ||
Patterns of comorbidity and dysfunction in clinically referred preschool and school-age children with bipolar disorder. | Q51008007 | ||
Oxcarbazepine in bipolar disorder. | Q51062907 | ||
Open-label lithium for the treatment of adolescents with bipolar depression. | Q51920328 | ||
Clozapine treatment in an adolescent with bipolar disorder. | Q52182969 | ||
Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. | Q52275733 | ||
Gabapentin in the acute treatment of refractory bipolar disorder. | Q53895639 | ||
A systematic chart review of the naturalistic course and treatment of early-onset bipolar disorder in a child and adolescent psychiatry center | Q35681875 | ||
The off-label use of clozapine in adolescents with bipolar disorder, intermittent explosive disorder, or posttraumatic stress disorder | Q35772747 | ||
Chart review of the impact of attention-deficit/hyperactivity disorder comorbidity on response to lithium or divalproex sodium in adolescent mania. | Q35868432 | ||
Improving the course of illness and promoting continuation of treatment of bipolar disorder. | Q35956697 | ||
Quetiapine adjunctive and monotherapy for pediatric bipolar disorder: a retrospective chart review | Q36009450 | ||
The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review | Q36015766 | ||
Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review. | Q36026701 | ||
Treatment guidelines for children and adolescents with bipolar disorder | Q36052032 | ||
Pharmacotherapy of children and adolescents with bipolar disorder | Q36096480 | ||
The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. | Q36192638 | ||
Maintenance therapies in bipolar disorder: focus on randomized controlled trials | Q36210974 | ||
Pediatric bipolar disorder: a review of the past 10 years | Q36237083 | ||
An open-label trial of risperidone in children and adolescents with bipolar disorder | Q40420633 | ||
Treatment of Bipolar Disorder in Children and Adolescents | Q40442918 | ||
Adjunctive antipsychotic treatment of adolescents with bipolar psychosis | Q40669405 | ||
A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder | Q40680619 | ||
Child and adolescent bipolar disorder: a review of the past 10 years | Q40882841 | ||
Early childhood attention deficit hyperactivity disorder predicts poorer response to acute lithium therapy in adolescent mania | Q41727635 | ||
Mood stabilizer augmentation with olanzapine in acutely manic children | Q41729170 | ||
Carbamazepine-induced mania in two children: case report. | Q42256147 | ||
Risperidone for young children with mood disorders and aggressive behavior | Q42541464 | ||
Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania | Q42608014 | ||
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. | Q42613693 | ||
A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. | Q42625302 | ||
Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial | Q42625897 | ||
Clozapine in the treatment of refractory psychotic mania | Q42627098 | ||
Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder | Q42627601 | ||
A pilot study of topiramate as monotherapy in the treatment of acute mania | Q42651172 | ||
Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design | Q42655106 | ||
A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder | Q42672419 | ||
Carbamazepine-induced mania with hypersexuality in a 9-year-old boy. | Q42682675 | ||
An open-label trial of divalproex in children and adolescents with bipolar disorder | Q42684910 | ||
Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group | Q43507067 | ||
Effectiveness of quetiapine in the management of psychotic depression in an adolescent boy with bipolar disorder, mixed, with psychosis | Q43661477 | ||
A new scale for measuring mania | Q44097504 | ||
Clozapine in adolescent inpatients with acute mania. | Q44109874 | ||
A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania | Q44168457 | ||
Topiramate plus risperidone for controlling weight gain and symptoms in preschool mania | Q44213135 | ||
Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design | Q44272770 | ||
Acute dysphoric mania: treatment response to olanzapine versus placebo | Q44364152 | ||
Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial | Q44385585 | ||
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder | Q44403599 | ||
Combination pharmacotherapy in children and adolescents with bipolar disorder | Q44466566 | ||
Lamotrigine in adolescent mood disorders | Q44486354 | ||
Combination lithium and divalproex sodium in pediatric bipolarity | Q44521424 | ||
Olanzapine versus placebo in acute mania: treatment responses in subgroups | Q44550787 | ||
A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 | ||
P433 | issue | 1 | |
P921 | main subject | bipolar disorder | Q131755 |
P304 | page(s) | 39-54 | |
P577 | publication date | 2006-11-09 | |
P1433 | published in | Psychopharmacology | Q1422802 |
P1476 | title | Psychopharmacology of pediatric bipolar disorder: a review | |
P478 | volume | 191 |
Q37703227 | Bipolar disorder in young people: Description, assessment and evidence-based treatment. |
Q37155306 | Comparison of aripiprazole and other atypical antipsychotics for pediatric bipolar disorder: a retrospective chart review of efficacy and tolerability |
Q36947163 | Effect of Tamoxifen and Lithium on Treatment of Acute Mania Symptoms in Children and Adolescents |
Q89044428 | Identifying clinical net benefit of psychotropic medication use with latent variable techniques: Evidence from Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) |
Q33985019 | Lithium use in special populations |
Q57804903 | PSYCHOTROPIC MEDICATIONS: AN UPDATE FOR SCHOOL PSYCHOLOGISTS |
Q37131034 | Pediatric bipolar disorder: recognition in primary care |
Q46185243 | Pharmacotherapy in bipolar disorders during childhood and adolescence |
Q36865365 | The Collaborative Lithium Trials (CoLT): specific aims, methods, and implementation |
Q36092635 | Topiramate versus Valproate Sodium as Adjunctive Therapies to a Combination of Lithium and Risperidone for Adolescents with Bipolar I Disorder: Effects on Weight and Serum Lipid Profiles |
Search more.